Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB): a meta-analysis

被引：0
|
作者：
Flacco, M. E. [1 ]
Manzoli, L. [2 ]
Rosso, A. [3 ]
Marzuillo, C. [3 ]
Bergamini, M. [4 ]
Stefanati, A. [4 ]
Villari, P. [3 ]
Ricciardi, W. [5 ]
Ioannidis, J. P. [6 ]
Contopoulos-Ioannidis, D. G. [7 ]
机构：
[1] Local Hlth Unit, Pescara, Italy
[2] Local Hlth Unit, Ferrara, Italy
[3] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy
[4] Univ Ferrara, Ferrara, Italy
[5] Italian Natl Inst Hlth, Rome, Italy
[6] Stanford Prevent Res Ctr, Stanford, CA USA
[7] Dept Pediat, Stanford, CA USA
来源：
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis
    Flacco, Maria Elena
    Manzoli, Lamberto
    Rosso, Annalisa
    Marzuillo, Carolina
    Bergamini, Mauro
    Stefanati, Armando
    Cultrera, Rosario
    Villari, Paolo
    Ricciardi, Walter
    Ioannidis, John P. A.
    Contopoulos-Ioannidis, Despina G.
    LANCET INFECTIOUS DISEASES, 2018, 18 (04): : 461 - 472
  • [2] Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis (vol 18, pg 461, 2018)
    Fiacco, M. E.
    Manzoli, L.
    Rosso, A.
    LANCET INFECTIOUS DISEASES, 2018, 18 (05): : 492 - 492
  • [3] Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia
    Marshall, H. S.
    Koehler, A. P.
    Wang, B.
    A'Houre, M.
    Gold, M.
    Quinn, H.
    Crawford, N.
    Pratt, N.
    Sullivan, T. R.
    Macartney, K.
    VACCINE, 2020, 38 (37) : 5914 - 5922
  • [4] Immunogenicity and safety of the meningococcal B recombinant (4CMenB) vaccine in allogeneic hematopoietic cell transplantation recipients
    Robin, Christine
    Redjoul, Rabah
    Terrade, Aude
    Deghmane, Ala-Eddine
    Cabanne, Ludovic
    Cordonnier, Catherine
    Taha, Muhamed-Kheir
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) : 1609 - 1614
  • [5] Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
    Abitbol, Veronique
    Sohn, Woo-Yun
    Horn, Michael
    Safadi, Marco Aurelio P.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [6] Reassuring safety data from the UK multicomponent meningococcal group B vaccine (4CMenB) programme
    Bettinger, Julie A.
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (06): : 380 - 381
  • [7] Meningococcal Group B Vaccine (4CMenB) in Children
    Lopez-Lacort, Monica
    Munoz-Quiles, Cintia
    Orrico-Sanchez, Alejandro
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (22): : 2109 - 2109
  • [8] MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
    Medini, Duccio
    Stella, Maria
    Wassil, James
    VACCINE, 2015, 33 (23) : 2629 - 2636
  • [9] Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
    Hong, Eva
    Terrade, Aude
    Muzzi, Alessandro
    De Paola, Rosita
    Boccadifuoco, Giuseppe
    La Gaetana, Rita
    Deghmane, Ala-Eddine
    Pizza, Mariagrazia
    Serino, Laura
    Taha, Muhamed-Kheir
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 5614 - 5622
  • [10] The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans
    Toneatto, Daniela
    Ismaili, Shevqet
    Ypma, Ellen
    Vienken, Kay
    Oster, Philipp
    Dull, Peter
    HUMAN VACCINES, 2011, 7 (06): : 646 - 653
12345